(Q39230272)

English

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls

scientific article published on 15 March 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Eleftherios P. Diamandis

6

object named as

Eleftherios P Diamandis

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Lennart Minthon

5

object named as

Lennart Minthon

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

author name string

Eduardo Martínez-Morillo

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Yuka Atagi

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Guojun Bu

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Henrietta M Nielsen

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

15 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Acta Neuropathologica

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

127

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

633-643

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Abnormal in vivo metabolism of apolipoprotein E4 in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E structure: insights into function.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Plasma lipoproteins: genetic influences and clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Binding of apolipoprotein E inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E: far more than a lipid transport protein

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

ApoE plasma levels and risk of cardiovascular mortality in old age

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Fluid biomarkers in Alzheimer's disease - current concepts

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E and cognitive performance: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

APOE ε4 increases risk for dementia in pure synucleinopathies

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Formation and function of apolipoprotein E-containing lipoproteins in the nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Amyloid associated proteins in Alzheimer's and prion disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Apolipoprotein E in Alzheimer's disease and other neurological disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

In vivo human apolipoprotein E isoform fractional turnover rates in the CNS

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1266-2

21 January 2018

Identifiers

10.1007/S00401-014-1266-2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39230272&oldid=2202704973"